🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07211529
Recruiting Not applicable

Intraoperative Paravertebral Block and Postoperative Complications

NCT07211529 · tracked via the Priya Life Science China tracker
Sponsor
Tongji Hospital
Phase
Not applicable
Started
2025-03-25
Last updated
2025-10-08

Condition(s) studied

Video-assisted Thoracoscopic Surgery (VATS)Lung Cancer (Diagnosis)Pulmonary InfectionsRespiratory Failure Without HypercapniaPleural Effusion Due to Another Disorder (Disorder)AtelectasisBronchospasmPneumothoraxPulmonary Embolism (Diagnosis)Bronchopleural FistulaAcute Respiratory Distress Syndrome (ARDS)

Investigational drug(s) / intervention(s)

Paravertebral Block (PVB)

Paravertebral Block (PVB): Participants in this arm will receive a paravertebral nerve block (PVB) performed intraoperatively under ultrasound guidance prior to the thoracic surgical procedure. The block will target the relevant thoracic vertebral levels corresponding to the surgical site. Standard local anesthetic agents will be administered according to institutional protocols. This intervention aims to provide perioperative analgesia, reduce postoperative pain, and potentially decrease the incidence of postoperative complications. All participants will also receive standard intraoperative monitoring and anesthesia management as per routine clinical practice.

Study summary

This study aims to evaluate the clinical association between intraoperative paravertebral block and the reduction of postoperative complications following thoracic surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Male or female participants aged 18 years or older. 2. Scheduled to undergo thoracic surgery via Video-Assisted Thoracoscopic Surgery (VATS) or Robotic-Assisted Thoracoscopic Surgery (RATS), including wedge resection, segmentectomy, lobectomy, or mediastinal surgery. 3. Signed informed consent obtained prior to study participation. - Exclusion Criteria: 1. Patients who refuse to provide informed consent. 2. Anesthesiologists who have not received training in ultrasound-guided paravertebral block (PVB-US). 3. History of ipsilateral thoracic surgery. 4. Conversion to open thoracotomy during the procedure. 5. Patients who did not complete the scheduled surgery due to disease progression or medical reasons. 6. Patients who are lost to follow-up or refuse postoperative follow-up. -

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tongji Medical College of HUST: Huazhong University of Science and Technology Tongji Medical College Tongji Hospital Wuhan Hubei Recruiting

More Tongji Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07211529 on ClinicalTrials.gov ↗ ← All trials in China